CCBE1 anticorps (Middle Region)
Aperçu rapide pour CCBE1 anticorps (Middle Region) (ABIN632573)
Antigène
Voir toutes CCBE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- CCBE1 antibody was raised against the middle region of CCBE1
-
Purification
- Affinity purified
-
Immunogène
- CCBE1 antibody was raised using the middle region of CCBE1 corresponding to a region with amino acids PMGPSPDLSHIKQGRRGPVGPPGAPGRDGSKGERGAPGPRGSPGPPGSFD
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CCBE1 Blocking Peptide, (ABIN5612702), is also available for use as a blocking control in assays to test for specificity of this CCBE1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CCBE1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CCBE1 (Collagen and Calcium Binding EGF Domains 1 (CCBE1))
-
Autre désignation
- CCBE1
-
Sujet
- This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans.
-
Poids moléculaire
- 44 kDa (MW of target protein)
Antigène
-